Longview Partners (Guernsey) portfolio
Concentrated managerInvestment firmPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 13, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Longview Partners (Guernsey) reported a $6.2 bn portfolio of 23 positions to the SEC as of the end of Q2 2026. Its largest positions are WST, UNH, TSM. During the quarter it opened Progressive and exited Nike and Fiserv.
Sections with a free account
What changed this quarter
26 positions with a change (1 new, 2 added to, 20 trimmed, 3 sold). 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Nike−3.8 ppof portfolioSold out3.8% → —
- Progressive+3.8 ppof portfolioNew— → 4.3%
- Fiserv−2.3 ppof portfolioSold out2.3% → —
- Marsh & Mclennan Companies−2.0 ppof portfolioSold out2.0% → —
- Texas Instruments−29%fewer sharesReduced4.2% → 5.2%
- UnitedHealth Group−25%fewer sharesReduced4.3% → 5.7%
- West Pharmaceutical Services−21%fewer sharesReduced4.7% → 6.0%
- Alphabet−21%fewer sharesReduced4.3% → 4.8%
- IQVIA Holdings−21%fewer sharesReduced4.6% → 4.7%
- American Express−21%fewer sharesReduced4.6% → 4.7%
- Visa−21%fewer sharesReduced4.4% → 4.6%
- Sysco−21%fewer sharesReduced4.0% → 4.2%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- West Pharmaceutical ServicesWST6.0%
- UnitedHealth GroupUNH5.7%
- Taiwan Semiconductor ManufacturingTSM5.5%
- Texas InstrumentsTXN5.2%
- AlphabetGOOGL4.8%
- IQVIA HoldingsIQV4.7%
- American ExpressAXP4.7%
- Cooper CompaniesCOO4.6%
- VisaV4.6%
- ProgressivePGR4.3%
- Thermo Fisher ScientificTMO4.3%
- CDWCDW4.3%
- Booking HoldingsBKNG4.3%
- MSCIMSCI4.2%
- SyscoSYY4.2%
“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.
Portfolio by sector
- ● Financials 35%
- ● Health Care 29%
- ● Information Technology 22%
- ● Communication Services 5%
- ● Consumer Discretionary 4%
- ● Consumer Staples 4%
How its portfolio changed (8 quarters)
Q2 2026: 23
Q2 2026: 50%
Q2 2026: 16.0%
Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Investment firm, per its Form ADV of Aug 25, 2026 (medium confidence).
The data, as reported: LONGVIEW PARTNERS (GUERNSEY) LIMITED (CRD 143875): 7.B no private funds; 5.D assets by client type: pooled vehicles 51%, governments 20%, sovereign funds 18%, pension plans 7% (of $11.5 bn)
The type comes from a rule applied to that data. If it looks wrong, tell us.
Similar managers by type and size
Same type of filer and a 13F portfolio value between a third and three times this one. It is not a comparison of what they hold.
- Alpha Wave GlobalInvestment firm · $6.2 bn
- Disciplined Growth InvestorsInvestment firm · $5.9 bn
- Ruane, Cunniff & GoldfarbInvestment firm · $6.4 bn
- Scge ManagementInvestment firm · $5.9 bn
- DSM Capital PartnersInvestment firm · $5.8 bn
- Kensico Capital ManagementInvestment firm · $5.8 bn